Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma-Reference-Cited by-同舟云学术

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

Published:2016-07-04 Issue:9 Volume:91 Page:923-930
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Jardin Fabrice¹,Pujals Anais²,Pelletier Laura²,Bohers Elodie¹,Camus Vincent¹,Mareschal Sylvain¹,Dubois Sydney¹,Sola Brigitte³,Ochmann Marlène⁴,Lemonnier François²,Viailly Pierre-Julien¹,Bertrand Philippe¹,Maingonnat Catherine¹,Traverse-Glehen Alexandra⁴,Gaulard Philippe²,Damotte Diane⁵,Delarue Richard⁶,Haioun Corinne²,Argueta Christian⁷,Landesman Yosef⁷,Salles Gilles⁸,Jais Jean-Philippe⁹,Figeac Martin¹⁰,Copie-Bergman Christiane²,Molina Thierry Jo¹¹,Picquenot Jean Michel¹,Cornic Marie¹,Fest Thierry⁴,Milpied Noel¹²,Lemasle Emilie¹,Stamatoullas Aspasia¹,Moeller Peter¹³,Dyer Martin J.S¹⁴,Sundstrom Christer¹⁵,Bastard Christian¹,Tilly Hervé¹,Leroy Karen²

Affiliation:

1. Departement of Hematology; Inserm U918, Centre Henri Becquerel; Rouen France

2. Departement of Hematology; Inserm U955 Team 09, APHP Hospital Henri Mondor; Créteil France

3. Departement of Hematology; Normandie Univ, UNICAEN; Caen EA4652 France

4. Departement of Hematology; Inserm U917, CHU Pontchaillou; Rennes France

5. Departement of Hematology; Hospices Civils De Lyon, Lyon-1 University; Pierre Benite CNRS UMR5239 France

6. Department of Pathology; Hôpitaux Universitaires, Paris Centre, Team « Cancer, Immune Control, and Escape » INSERM U1138, Cordeliers Research Center; Paris France

7. Department of Hematology; Necker Hospital, AP-HP; Paris France

8. Karyopharm Therapeutics; Newton MA

9. Department of Biostatistics; Hopital Necker; Paris France

10. Departement of Genomics; Functional Genomic Platforms, IRCL; Lille France

11. Department of Pathology; Necker Hospital, AP-HP; Paris France

12. Department of Hematology; CHU De Bordeaux France

13. Department of Pathology; Institute of Pathology, University of Ulm; Germany

14. Department of Hematology; Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester; United Kingdom

15. Department of Pathology; Uppsala Sweden

Funder

French National Institute of Cancer (INCA)

Cancer Research Association (ARC)